Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chiasma
Biotech
Ex-Novartis, Chiasma leader joins Recordati Rare Diseases as CMO
William Ludlam, M.D., Ph.D., joins Recordati Rare Diseases as CMO. He was Chiasma's SVP of clinical development after medical roles at Novartis.
Kyle LaHucik
Aug 25, 2021 12:37pm
Endocrine specialist Crinetics tees up for $86M IPO
Jun 25, 2018 8:15am
Crinetics raises $63.5M for oral acromegaly therapy
Mar 14, 2018 9:10am
EuroBiotech Report: Chiasma axes 33% of staff as approval hopes fade
Jun 16, 2016 11:05am
Ax falls on 33% of Chiasma staff after trial design doubts scuttle approval hopes
Jun 15, 2016 4:44am
